
Moxidectin: A New alternative for Treating a Hidden Parasite: Strongyloides stercoralis
The microscopic parasite Strongyloides stercoralis infects millions of humans worldwide, often without symptoms. For years, the treatment of choice has been ivermectin, a drug that has been recognized for its use in combating diseases, such as river blindness. However, what is another option? Our recent study compared ivermectin to its lesser-known antiparasitic, moxidectin, and the results were promising.